November marks National Alzheimer’s Disease Awareness Month in the United States, serving as a crucial reminder of the millions affected by the disease. This observance, established in 1983, has become increasingly relevant as new disease-modifying treatments gain momentum in the marketplace.For investors, this period provides a timely lens to evaluate the healthcare sector, particularly companies that are at the forefront of the fight against Alzheimer's. This focus makes Healthcare exchange-traded funds ( ...